Gunther Pendl

Background

About Gunther Pendl

Innovation and science driven creative leader with strong presentation skills. Long term focused strategic mind in combination with pragmatic sense of urgency and determined drive for results. Communicative, self-motivated and inspiring matrix worker who leads medical teams by example and walks the talk:• +15 years of experience in biotechnology/pharmaceutical industry• Data driven scientific and medical expert with strong marketing know-howKey Achievements:• Support of relaunch plan of Aranesp® as third ESA in Germany with market research and long term sales forecast, worldwide sales in 2006 > 4 billion USD• Support of Mimpara® launch in Germany, worldwide sales > 1 billion USD achieved in 2013• Lead for European market research projects (systematic commercial analysis) for Prolia® launch, managing budget of > 2 million USD• Implementation and maintenance of European Key Opinion Leader plan for Prolia® launch readiness within European medical affairs team, more than 500 experts listed• Achievement of 1st line status for Prolia® in Switzerland, Prix Galien awarded in 2012, double digit growth rate in flat market since launch, sales >30 million CHF in 2016• Implementation of several observational studies and investigator sponsored trials in Switzerland, investment worth > 5 million CHF• Establishment of local stand-alone CME series (“Bone Academy”, “Swiss Lipid Academy”) with more than 10 local events and 50 to 150 attendees each• Successful development of top performing Regional Medical Liaison Manager to Sr. Medical Advisor